Evidence map›Paper›PMID 24795840›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2014

PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM,radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate.

Tomoteru Yamasaki, Jun Maeda, Masayuki Fujinaga, Yuji Nagai, Akiko Hatori, Joji Yui, Lin Xie, Nobuki Nengaki, Ming-Rong Zhang

Open access · greenAbstract read
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. A Review of Molecular Imaging of Glutamate Receptors.Molecules (Basel, Switzerland) · 2020
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Tomoteru YamasakiMolecular Probe Program, Molecular Imaging Center, National Institute of Radiological Sciences Inage-ku, Chiba, Japan.
Jun MaedaMolecular Neuroimaging Program, Molecular Imaging Center, National Institute of Radiological Sciences Inage-ku, Chiba, Japan.
Masayuki FujinagaMolecular Probe Program, Molecular Imaging Center, National Institute of Radiological Sciences Inage-ku, Chiba, Japan.
Yuji NagaiMolecular Neuroimaging Program, Molecular Imaging Center, National Institute of Radiological Sciences Inage-ku, Chiba, Japan.
Akiko HatoriMolecular Probe Program, Molecular Imaging Center, National Institute of Radiological Sciences Inage-ku, Chiba, Japan.
Joji YuiMolecular Probe Program, Molecular Imaging Center, National Institute of Radiological Sciences Inage-ku, Chiba, Japan.
Lin XieMolecular Probe Program, Molecular Imaging Center, National Institute of Radiological Sciences Inage-ku, Chiba, Japan.
Nobuki NengakiShi Accelerator Service Co. Ltd Shinagawa-ku, Tokyo, Japan.
Ming-Rong ZhangMolecular Probe Program, Molecular Imaging Center, National Institute of Radiological Sciences Inage-ku, Chiba, Japan.
Institute of Medicinal Molecular Design · JPInstitute of Molecular Bioimaging and Physiology · ITSony Computer Science Laboratories · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The metabotropic glutamate receptor type 1 (mGluR1) is a novel target protein for the development of new drugs against central nervous system disorders. Recently, we have developed (11)C-labeled PET probes (11)C-ITMM and (11)C-ITDM, which demonstrate similar profiles, for imaging of mGluR1. In the present study, we compared (11)C-ITMM and (11)C-ITDM PET imaging and quantitative analysis in the monkey brain. Respective PET images showed similar distribution of uptake in the cerebellum, thalamus, and cingulate cortex. Slightly higher uptake was detected with (11)C-ITDM than with (11)C-ITMM. For the kinetic analysis using the two-tissue compartment model (2-TCM), the distribution volume (VT) in the cerebellum, an mGluR1-rich region in the brain, was 2.5 mL∙cm(-3) for (11)C-ITMM and 3.6 mL∙cm(-3) for (11)C-ITDM. By contrast, the VT in the pons, a region with negligible mGluR1 expression, was similarly low for both radiopharmaceuticals. Based on these results, we performed noninvasive PET quantitative analysis with general reference tissue models using the time-activity curve of the pons as a reference region. We confirmed the relationship and differences between the reference tissue models and 2-TCM using correlational scatter plots and Bland-Altman plots analyses. Although the scattergrams of both radiopharmaceuticals showed over- or underestimations of reference tissue model-based the binding potentials against 2-TCM, there were no significant differences between the two kinetic analysis models. In conclusion, we first demonstrated the potentials of (11)C-ITMM and (11)C-ITDM for noninvasive PET quantitative analysis using reference tissue models. In addition, our findings suggest that (11)C-ITDM may be superior to (11)C-ITMM as a PET probe for imaging of mGluR1, because regional VT values in PET with (11)C-ITDM were higher than those of (11)C-ITMM. Clinical studies of (11)C-ITDM in humans will be necessary in the future.

Indexed as

Central nervous system (CNS)metabotropic glutamate receptor type 1 (mGluR1)positron emission tomography (PET)

Identifiers

PMID24795840
PMCPMC3999406
OpenAlexW2280279811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.